BioInfra Co., Ltd. (KOSDAQ:199730)
South Korea
· Delayed Price · Currency is KRW 4,165.00
-20.00 (-0.48%)
At close: Apr 28, 2026
BioInfra Market Cap
BioInfra has a market cap or net worth of 20.26 billion as of April 28, 2026. Its market cap has decreased by -35.53% in one year.
Market Cap
20.26B
Enterprise Value
23.95B
Revenue
23.15B
Ranking
n/a
PE Ratio
n/a
Stock Price
4,165.00
Market Cap Chart
Since March 2, 2023, BioInfra's market cap has decreased from 141.03B to 20.26B, a decrease of -85.63%. That is a compound annual growth rate of -45.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 20.26B | -11.95% |
| Dec 30, 2025 | 23.01B | -26.09% |
| Dec 30, 2024 | 31.13B | -46.41% |
| Dec 28, 2023 | 58.09B | -58.81% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SLS BIO | 26.89B |
| Curachem | 12.28B |
| C&R Research | 44.77B |
| DT&CRO CO. | 45.58B |
| WOOJUNG BIO | 50.74B |
| Cronex.Co.,Ltd | 5.97B |
| P&K Skin Research Center | 73.65B |
| MEDIZEN HUMANCARE | 4.61B |